ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682095; 2) Community: the network communities that were significantly associated with the response to NSC 682095; 3) Molecule: the relationships between components within communities and NSC 682095; 4) MDR: the compounds that were significantly associated with the NSC 682095.

NSC Compound Enrichment Correlation
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0385613993886001 0.14998547
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.0385613993886001 0.18730163
NSC 35489 Null 0.0385613993886001 0.48183954
NSC 361887 1H-Purine-2,6-dione, 8-[3-(dimethylamino)propoxy]-3,7- dihydro-1,3,7-trimethyl-, mixt. with 1,7-dihydro-6H- purine-6-thione 0.0385613993886001 -0.047843554
NSC 379546 Null 0.0385613993886001 0.35747782
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0385613993886001 0.21908986
NSC 619961 Primaquine diphosphate 0.0385613993886001 0.25210456
NSC 620256 Platinate(2-), tetrachloro-, (SP-4-1), 9-hydroxy-2,5,11- trimethyl-6H-pyrido[4,3-b]carbazolium (1:2) 0.0385613993886001 0.13463903
NSC 622075 Null 0.0385613993886001 0.08506995
NSC 626390 Null 0.0385613993886001 -0.10427879
Total:76  Current:59    [First] [Prev] [Next] [Last]